Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.03M.
ENTERPRISE VALUE (EV)
$1.03M
GT Biopharma, Inc.
Market Cap
$7.84M
Enterprise Value (EV)
$1.03M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| GT Biopharma, Inc. (GTBP) | $7.84M | $1.03M |
| HeartSciences Inc. (HSCS)vs › | $7.78M | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.89M | N/A |
| Longeveron Inc. (LGVN)vs › | $7.46M | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.28M | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.36M | $7.13M |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | $5.11M |
| Mangoceuticals, Inc. (MGRX)vs › | $7.22M | $7.31M |
| DataMEDS AI, Inc. (MEDS)vs › | $8.47M | $38.64M |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.48M | $19.58M |
Market Cap
$7.84M
Total Debt
$0.00
Cash
$6.81M
Enterprise Value
$1.03M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
